Concepedia

Lukas Rindlisbacher

LR

7

Publications

452

Citations

7

H-Index

2021

Active since

Affiliations

University of Zurich(Current)

Heidelberg University

University of Rijeka

Technical University of Munich

German Cancer Research Center

Lukas Rindlisbacher is an author at University of Zurich specializing in tumor biology, t cell immunity, and tumor immunity.

ORCID

Top concepts

Publications per year

2021–2024

7

Publications

7

Intratumoral IL-12 delivery empowers CAR-T cell immunotherapy in a pre-clinical model of glioblastoma

Giulia Agliardi, Anna Rita Liuzzi, Alastair Hotblack et al. · Nature Communications · 2021 · 276 citations · Full text

IL-23 stabilizes an effector Treg cell program in the tumor microenvironment

Tobias Wertheimer, Pascale Zwicky, Lukas Rindlisbacher et al. · Nature Immunology · 2024 · 47 citations · Full text

Targeted delivery of tumor necrosis factor in combination with CCNU induces a T cell–dependent regression of glioblastoma

Thomas Look, Emanuele Puca, Marcel Bühler et al. · Science Translational Medicine · 2023 · 33 citations

, , +19

NKG2D-mediated detection of metabolically stressed hepatocytes by innate-like T cells is essential for initiation of NASH and fibrosis

Sonja Marinović, Maja Lenartić, Karlo Mladenić et al. · Science Immunology · 2023 · 31 citations · Full text

MDM2 Inhibition Enhances Immune Checkpoint Inhibitor Efficacy by Increasing IL15 and MHC Class II Production

Marlene Langenbach, Sophie Giesler, Stefan Richtsfeld et al. · Molecular Cancer Research · 2023 · 25 citations · Full text

Rows per page

1–5 of 7